Evidence map›Paper›PMID 33669483›Full record

ArticleCells2021

Comparison of Monoclonal Gammopathies Linked to Poliovirus or Coxsackievirus vs. Other Infectious Pathogens.

Jean Harb, Nicolas Mennesson, Cassandra Lepetit, Maeva Fourny, Margaux Louvois, Adrien Bosseboeuf, Sophie Allain-Maillet, Olivier Decaux, Caroline Moreau, Anne Tallet and 5 more

Abstract read
In one paragraph

Article in Cells, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Jean HarbCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.
Nicolas MennessonCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.
Cassandra LepetitCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.
Maeva FournyCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.
Margaux LouvoisCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.
Adrien BosseboeufCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.
Sophie Allain-MailletCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.
Olivier DecauxInternal Medicine, CHU de Rennes, 35000 Rennes, France.
Caroline MoreauLaboratoire de Biochimie, CHU de Rennes, 35000 Rennes, France.
Anne TalletLaboratoire de PGMC, CHU de Tours, 37000 Tours, France.
Eric PiverLaboratoire de Biochimie, CHU de Tours, 37000 Tours, France.ORCID 0000-0002-7101-0121
Philippe MoreauHematology Department, CHU Nantes, 44000 Nantes, France.
Valéry SalleInternal Medicine, CHU Amiens, 80000 Amiens, France.
Edith Bigot-CorbelCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.ORCID 0000-0002-2760-8740
Sylvie HermouetCRCINA, Inserm, Université de Nantes, Université d'Angers, 44000 Nantes, France.ORCID 0000-0001-5444-4406

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic stimulation by infectious pathogens or self-antigen glucosylsphingosine (GlcSph) can lead to monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM). Novel assays such as the multiplex infectious antigen microarray (MIAA) and GlcSph assays, permit identification of targets for >60% purified monoclonal immunoglobulins (Igs). Searching for additional targets, we selected 28 purified monoclonal Igs whose antigen was not represented on the MIAA and GlcSph assays; their specificity of recognition was then analyzed using microarrays consisting of 3760 B-cell epitopes from 196 pathogens. The peptide sequences PALTAVETG and PALTAAETG of the VP1 coat proteins of human poliovirus 1/3 and coxsackievirus B1/B3, respectively, were specifically recognized by 6/28 monoclonal Igs. Re-analysis of patient cohorts showed that purified monoclonal Igs from 10/155 MGUS/SM (6.5%) and 3/147 MM (2.0%) bound to the PALTAVETG or PALTAAETG epitopes. Altogether, PALTAV/AETG-initiated MGUS are not rare and few seem to evolve toward myeloma.

Indexed as

AdultAgedAged, 80 and overCoxsackievirus InfectionsHumansMiddle AgedParaproteinemiasPoliovirusRetrospective Studiesantigen specificitycoxsackievirusinfectionMGUSmonoclonal gammopathymonoclonal immunoglobulinmultiple myelomapathogenpoliovirus

Identifiers

PMID33669483
PMCPMC7922508

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.